107 related articles for article (PubMed ID: 8107280)
21. [Acquired autoantibodies against human factor VIII: a new case].
Cailleux N; Levesque H; Courtois H; Borg JY
J Mal Vasc; 1996; 21(5):324-8. PubMed ID: 9026552
[TBL] [Abstract][Full Text] [Related]
22. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
Arai M
Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
[TBL] [Abstract][Full Text] [Related]
23. [Immunoblotting analysis of acquired factor VIII inhibitor in an elderly man].
Kikuchi M; Sano M; Shimamoto Y; Yamaguchi M; Tadano J; Takahashi I; Kamiya T
Rinsho Ketsueki; 1993 Jul; 34(7):876-8. PubMed ID: 7689663
[TBL] [Abstract][Full Text] [Related]
24. [Acquired factor VIII deficiency treated with cyclosporine].
Leinøe EB; Jørgensen M; Nielsen JD
Ugeskr Laeger; 1999 Aug; 161(34):4762-3. PubMed ID: 10500467
[TBL] [Abstract][Full Text] [Related]
25. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
26. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain.
Laub R; Di Giambattista M; Fondu P; Brackmann HH; Lenk H; Saenko EL; Felch M; Scandella D
Thromb Haemost; 1999 Jan; 81(1):39-44. PubMed ID: 9974372
[TBL] [Abstract][Full Text] [Related]
28. Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors.
Sawamoto Y; Prescott R; Zhong D; Saenko EL; Mauser-Bunschoten E; Peerlinck K; van den Berg M; Scandella D
Thromb Haemost; 1998 Jan; 79(1):62-8. PubMed ID: 9459325
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
[TBL] [Abstract][Full Text] [Related]
30. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.
Green D; Lechner K
Thromb Haemost; 1981 Jun; 45(3):200-3. PubMed ID: 6792737
[TBL] [Abstract][Full Text] [Related]
31. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic methodologies for circulating anticoagulants.
Exner T
Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481
[TBL] [Abstract][Full Text] [Related]
33. Mapping factor VIII inhibitor epitopes using hybrid human/porcine factor VIII molecules.
Lollar P
Haematologica; 2000 Oct; 85(10 Suppl):26-8; discussion 28-30. PubMed ID: 11187866
[TBL] [Abstract][Full Text] [Related]
34. [Acquired factor VIII hemophilia in a geriatric patient].
Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
[TBL] [Abstract][Full Text] [Related]
35. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
Peerlinck K; Arnout J; Di Giambattista M; Gilles JG; Laub R; Jacquemin M; Saint-Remy JM; Vermylen J
Thromb Haemost; 1997 Jan; 77(1):80-6. PubMed ID: 9031454
[TBL] [Abstract][Full Text] [Related]
36. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
37. Immunological analysis of acquired factor VIII inhibitor in a case with immunologic disorder.
Okamura T; Yamauchi Y; Fukuda T; Suehiro K; Murakawa M; Shibuya T; Nagasawa K; Harada M; Niho Y
Acta Haematol; 1991; 85(3):153-5. PubMed ID: 1710410
[TBL] [Abstract][Full Text] [Related]
38. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
[TBL] [Abstract][Full Text] [Related]
39. [Autoantibodies against coagulation factor VIII].
Friis-Hansen LJ; Andersen NS; Scheibel E
Ugeskr Laeger; 1998 Oct; 160(42):6061-5. PubMed ID: 9800508
[TBL] [Abstract][Full Text] [Related]
40. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
Scandella D
Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
